Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/57837
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGullapelli, Kumaraswamy-
dc.contributor.authorMaroju, Ravichandar-
dc.contributor.authorMerugu, Ramchander-
dc.date.accessioned2021-08-05T06:01:37Z-
dc.date.available2021-08-05T06:01:37Z-
dc.date.issued2021-05-
dc.identifier.issn0975-0991 (Online); 0971-457X (Print)-
dc.identifier.urihttp://nopr.niscair.res.in/handle/123456789/57837-
dc.description343-350en_US
dc.description.abstractThe present study is the synthesis of new heterocyclic moieties like pyrazole, isoxazole and thiazole containing benzimidazole nucleus. The title compounds were synthesized from 4-(1H-benzo[d]imidazol-2-yl) oxazol-2-amine. The newly synthesised compounds were screened for their in vitro anti-inflammatory activity and demonstrated excellent to moderate activity and molecular docking study reports are supporting anti-inflammatory activity showed high inhibition constant and binding energy. The structures of synthesised compounds were characterized by IR, 1HNMR, Mass spectroscopic methods.en_US
dc.publisherNIScPR-CSIR, Indiaen_US
dc.sourceIJCT Vol.28(3) [May 2021]en_US
dc.subjectBenzimidazoleen_US
dc.subjectDocking studyen_US
dc.subjectIsoxazoleen_US
dc.subjectPyrazoleen_US
dc.subjectSynthesisen_US
dc.titleAn efficient synthesis, invitro and insilco evaluation of new pyrazole and isoxazole derivatives as anti-inflammatory agentsen_US
dcterms.publisherNISCAIR-CSIR, Indiaen_US
dcterms.sourceIJCT Vol.28(3) [May 2021]en_US
Appears in Collections:IJCT Vol.28(3) [May 2021]

Files in This Item:
File Description SizeFormat 
IJCT 28(3) 343-350.pdf397.2 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.